PORRO, ALBERTO
PORRO, ALBERTO
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Assegnisti
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients
2019 Ravaioli, F.; Dajti, E.; Simoni, P.; Porro, A.; Marasco, G.; Alemanni, L.V.; Tamè, M.; Brillanti, S.; Colecchia, A.; Montagnani, M.; Festi, D.; Mazzella, G.; Azzaroli, F.
IL28 polymorphism and HCC after DAAs for chronic hepatitis C
2018 Simili, A.; Mazzella, G.; Ravaioli, F.; Davide, F.; Bacchi-Reggiani, M.L.; Porro, A.; Bazzoli, F.; Azzaroli, F.
P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C
2018 Simili, A.; Mazzella, G.; Ravaioli, F.; Festi, D.; Reggiani, M.L. Bacchi; Porro, A.; Bazzoli, F.; Azzaroli, F.
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older
2017 Conti, F.; Brillanti, S.; Buonfiglioli, F.; Vukotic, R.; Morelli, M.C.; Lalanne, C.; Massari, M.; Foschi, F.G.; Bernabucci, V.; Serio, I.; Prati, G.M.; Negri, E.; Badia, L.; Caraceni, P.; Muratori, P.; Vitale, G.; Porro, A.; Morotti, M.; Mazzella, G.; Andreone, P.
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens
2017 Ravaioli, F.; Marasco, G.; Bacchi Reggiani, M.L.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Brillanti, S.; Colecchia, A.; Festi, D.
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens
2017 Ravaioli, F.; Marasco, G.; Reggiani, M.L.B.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Brillanti, S.; Colecchia, A.; Festi, D.
Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma
2014 Lisotti, Andrea; Azzaroli, Francesco; Montagnani, Marco; Porro, Alberto; Mazzella, Giuseppe
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis.
2014 Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M; Cecinato P; Calvanese, C; Patrizia, S; Porro, A; Fiorillo, D; Cucchetti A; Colecchia A, Golfieri R, Festi D, Mazzella G.
The future of dual therapy for hepatitis C virus
2014 Azzaroli, Francesco; Montagnani, Marco; Porro, Alberto; Fiorillo, Domenico; Mazzella, Giuseppe
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis
2013 Lisotti A, Azzaroli F, Buonfiglioli F, Cecinato P, Montagnani M, Arena R, Calvanese C, Simoni P, Belvisi S, Porro A, Cucchetti A, Colecchia A, Festi D, Golfieri R, Mazzella G
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis
2012 Lisotti A; Azzaroli F; Buonfiglioli F; Cecinato P; Montagnani M; Simoni P; Calvanese C; Arena R; Grande G; Belvisi S; Porro A; Cucchetti A; Colecchia A; Festi D; Golfieri R; Mazzella G
Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis.
2012 Lisotti A, Azzaroli F, Buonfiglioli F Cecinato P, Montagnani M, Patrizia S, Calvanese C, Arena R, Grande G, Belvisi S, Porro A, Cucchetti A, Colecchia A, Festi D, Golfieri R, Mazzella G
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients | Ravaioli, F.; Dajti, E.; Simoni, P.; Porro, A.; Marasco, G.; Alemanni, L.V.; Tamè, M.; Brillanti,... S.; Colecchia, A.; Montagnani, M.; Festi, D.; Mazzella, G.; Azzaroli, F. | 2019-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
| IL28 polymorphism and HCC after DAAs for chronic hepatitis C | Simili, A.; Mazzella, G.; Ravaioli, F.; Davide, F.; Bacchi-Reggiani, M.L.; Porro, A.; Bazzoli, F....; Azzaroli, F. | 2018-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C | Simili, A.; Mazzella, G.; Ravaioli, F.; Festi, D.; Reggiani, M.L. Bacchi; Porro, A.; Bazzoli, F.;... Azzaroli, F. | 2018-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older | Conti, F.; Brillanti, S.; Buonfiglioli, F.; Vukotic, R.; Morelli, M.C.; Lalanne, C.; Massari, M.;... Foschi, F.G.; Bernabucci, V.; Serio, I.; Prati, G.M.; Negri, E.; Badia, L.; Caraceni, P.; Muratori, P.; Vitale, G.; Porro, A.; Morotti, M.; Mazzella, G.; Andreone, P. | 2017-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
| Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens | Ravaioli, F.; Marasco, G.; Bacchi Reggiani, M.L.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Bril...lanti, S.; Colecchia, A.; Festi, D. | 2017-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens | Ravaioli, F.; Marasco, G.; Reggiani, M.L.B.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Brillanti..., S.; Colecchia, A.; Festi, D. | 2017-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma | Lisotti, Andrea; Azzaroli, Francesco; Montagnani, Marco; Porro, Alberto; Mazzella, Giuseppe | 2014-01-01 | JOURNAL OF GASTROENTEROLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. | Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M; Cecinato P; Calvanese, C; Patrizia, S; Porro..., A; Fiorillo, D; Cucchetti A; Colecchia A, Golfieri R, Festi D, Mazzella G. | 2014-01-01 | HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| The future of dual therapy for hepatitis C virus | Azzaroli, Francesco; Montagnani, Marco; Porro, Alberto; Fiorillo, Domenico; Mazzella, Giuseppe | 2014-01-01 | FUTURE VIROLOGY | - | 1.01 Articolo in rivista | - |
| Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis | Lisotti A, Azzaroli F, Buonfiglioli F, Cecinato P, Montagnani M, Arena R, Calvanese C, Simoni P, ...Belvisi S, Porro A, Cucchetti A, Colecchia A, Festi D, Golfieri R, Mazzella G | 2013-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis | Lisotti A; Azzaroli F; Buonfiglioli F; Cecinato P; Montagnani M; Simoni P; Calvanese C; Arena R; ...Grande G; Belvisi S; Porro A; Cucchetti A; Colecchia A; Festi D; Golfieri R; Mazzella G | 2012-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis. | Lisotti A, Azzaroli F, Buonfiglioli F Cecinato P, Montagnani M, Patrizia S, Calvanese C, Arena R..., Grande G, Belvisi S, Porro A, Cucchetti A, Colecchia A, Festi D, Golfieri R, Mazzella G | 2012-01-01 | HEPATOLOGY | - | 1.06 Abstract in rivista | - |